To assess the effect of ADSC-EVs treatment on angiogenesis in mice after cerebral ischemia, we used CD31 immunofluorescence staining to detect the fluorescence intensity and number of microvessels in the peripheral region of cerebral ischemia at 14 days after tMCAO (Fig. 3D). This evidence concerns the gene PECAM1 and Cerebral ischemia.